CORONAVIRUS DISEASE-2019 CHARACTERISTICS AMONG THAI ADULTS REINFECTED WITH SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS-2

Some severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) omicron subvariants may be resistant to vaccines and/or infection-induced immunity increasing the risk for reinfection. In this study, we aimed to determine coronavirus disease-2019 (COVID-19) severity, need for hospitalization, sympt...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Southeast Asian journal of tropical medicine and public health 2024-05, Vol.55 (3), p.71-86
Hauptverfasser: Assawakosri, Suvichada, Sudhinaraset, Natthinee, Chansaenroj, Jira, Suntronwong, Nungruthai, Kanokudom, Sitthichai, Nalinpakorn, Natach, Tantipraphat, Napat, Sethabutra, Amica, Honsawek, Sittisak, Poovorawan, Yong
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 86
container_issue 3
container_start_page 71
container_title Southeast Asian journal of tropical medicine and public health
container_volume 55
creator Assawakosri, Suvichada
Sudhinaraset, Natthinee
Chansaenroj, Jira
Suntronwong, Nungruthai
Kanokudom, Sitthichai
Nalinpakorn, Natach
Tantipraphat, Napat
Sethabutra, Amica
Honsawek, Sittisak
Poovorawan, Yong
description Some severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) omicron subvariants may be resistant to vaccines and/or infection-induced immunity increasing the risk for reinfection. In this study, we aimed to determine coronavirus disease-2019 (COVID-19) severity, need for hospitalization, symptoms and time to reinfection with SARS-CoV-2 among previously infected Thai adults in order to inform efforts to control COVID-19 in Thailand. The study subjects were Thais aged >18 years, currently living in Thailand who had two previous COVID-19 infections at least 90 days apart confirmed by either an antigen test or COVID-19 real-time polymerase chain reaction testing, where the reinfection was presumed to be an omicron variant based on the most prominent strain of COVID-19 occurring at the time of reinfection. Study subjects were recruited via advertisements on the social media applications Line and Facebook. Each subject was asked to complete an online questionnaire asking about demographic data, dates of COVID-19 infections, time from the initial infection to reinfection, severity of infection, hospitalizations and symptoms during both infections. The minimum number of subjects determined to be needed for the study was 220. The study was conducted during 12-31 January 2023. A total of 201 subjects were included in the study, 59.7% female. The mean(standard deviation (SD)) age of study subjects was 44.3 (11.4) (range: 20-81) years. The symptoms significantly more common in the first infection than the second infection were: anosmia (36.8%vs 13.9%) (p
format Article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_3108816832</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3108816832</sourcerecordid><originalsourceid>FETCH-LOGICAL-p183t-b2788435614b67cbbdf32521c3aeec15886675030d023cf71d1dd4a0f53d4f063</originalsourceid><addsrcrecordid>eNpNjbtqwzAARTW0kDTNPwg6C_SwZHUUshILHKtIckqmYFv2EEqTxsnSr6-hHTrd4VzOeQBLTChHhAu6AE_TdMI4w-RVLsG3dt7Vam99E2Bhg1HBIDozqEvllY7G2xCtDlDtXL2FsVQWqqKpYoDe2Hpj5ksB320sYTB74w1UuolmhuHNehWdP8BwqAvvdgb-iyH6DB7H9mMa1n-7As3GRF2iym2tVhW6EMluqKO5lBnjgmSdyPuuSyOjnJKetcPQEy6lEDnHDCdMWT_mJJGUshaPnKVsxIKtwMuv93I9f92H6XY8ne_Xzzl5ZARLSYRklP0AgOZNiA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3108816832</pqid></control><display><type>article</type><title>CORONAVIRUS DISEASE-2019 CHARACTERISTICS AMONG THAI ADULTS REINFECTED WITH SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS-2</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Assawakosri, Suvichada ; Sudhinaraset, Natthinee ; Chansaenroj, Jira ; Suntronwong, Nungruthai ; Kanokudom, Sitthichai ; Nalinpakorn, Natach ; Tantipraphat, Napat ; Sethabutra, Amica ; Honsawek, Sittisak ; Poovorawan, Yong</creator><creatorcontrib>Assawakosri, Suvichada ; Sudhinaraset, Natthinee ; Chansaenroj, Jira ; Suntronwong, Nungruthai ; Kanokudom, Sitthichai ; Nalinpakorn, Natach ; Tantipraphat, Napat ; Sethabutra, Amica ; Honsawek, Sittisak ; Poovorawan, Yong</creatorcontrib><description>Some severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) omicron subvariants may be resistant to vaccines and/or infection-induced immunity increasing the risk for reinfection. In this study, we aimed to determine coronavirus disease-2019 (COVID-19) severity, need for hospitalization, symptoms and time to reinfection with SARS-CoV-2 among previously infected Thai adults in order to inform efforts to control COVID-19 in Thailand. The study subjects were Thais aged &gt;18 years, currently living in Thailand who had two previous COVID-19 infections at least 90 days apart confirmed by either an antigen test or COVID-19 real-time polymerase chain reaction testing, where the reinfection was presumed to be an omicron variant based on the most prominent strain of COVID-19 occurring at the time of reinfection. Study subjects were recruited via advertisements on the social media applications Line and Facebook. Each subject was asked to complete an online questionnaire asking about demographic data, dates of COVID-19 infections, time from the initial infection to reinfection, severity of infection, hospitalizations and symptoms during both infections. The minimum number of subjects determined to be needed for the study was 220. The study was conducted during 12-31 January 2023. A total of 201 subjects were included in the study, 59.7% female. The mean(standard deviation (SD)) age of study subjects was 44.3 (11.4) (range: 20-81) years. The symptoms significantly more common in the first infection than the second infection were: anosmia (36.8%vs 13.9%) (p&lt;0.001), dyspnea (36.3% vs 18.9%) (p&lt;0.001) and myalgia (60.2%vs 43.8%) (=&lt;0.001), respectively. The hospitalization rate was significantly higher during the first infection than the second infection (14.9% vs 3.5%; crude odds ratio (cOR) = 6.25; 95% confidence interval (CI): 2.16-24.71; p&lt;0.001). The average time from first infection to reinfection was 263 (range: 96-725) days. In summary, anosmia, dyspnea, myalgia, and hospitalizations were more common during first than the second COVID-19 infection among study subjects and the time between infections averaged 9 months. We conclude, as COVID-19 immunity decreases over time, there is a need for a booster, possibly updated, vaccine to reduce the risk for reinfection.</description><identifier>ISSN: 0125-1562</identifier><language>eng</language><publisher>Bangkok: Central Coordinating Board, SEAMEO-TROPMED Project</publisher><subject>Adults ; Anosmia ; Coronaviruses ; COVID-19 ; Dyspnea ; Immunity ; Infections ; Myalgia ; Olfaction disorders ; Polymerase chain reaction ; Real time ; Respiration ; Respiratory diseases ; Severe acute respiratory syndrome coronavirus 2 ; Signs and symptoms ; Social networks ; Vaccines ; Viral diseases</subject><ispartof>Southeast Asian journal of tropical medicine and public health, 2024-05, Vol.55 (3), p.71-86</ispartof><rights>Copyright Central Coordinating Board, SEAMEO-TROPMED Project May 2024</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780</link.rule.ids></links><search><creatorcontrib>Assawakosri, Suvichada</creatorcontrib><creatorcontrib>Sudhinaraset, Natthinee</creatorcontrib><creatorcontrib>Chansaenroj, Jira</creatorcontrib><creatorcontrib>Suntronwong, Nungruthai</creatorcontrib><creatorcontrib>Kanokudom, Sitthichai</creatorcontrib><creatorcontrib>Nalinpakorn, Natach</creatorcontrib><creatorcontrib>Tantipraphat, Napat</creatorcontrib><creatorcontrib>Sethabutra, Amica</creatorcontrib><creatorcontrib>Honsawek, Sittisak</creatorcontrib><creatorcontrib>Poovorawan, Yong</creatorcontrib><title>CORONAVIRUS DISEASE-2019 CHARACTERISTICS AMONG THAI ADULTS REINFECTED WITH SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS-2</title><title>Southeast Asian journal of tropical medicine and public health</title><description>Some severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) omicron subvariants may be resistant to vaccines and/or infection-induced immunity increasing the risk for reinfection. In this study, we aimed to determine coronavirus disease-2019 (COVID-19) severity, need for hospitalization, symptoms and time to reinfection with SARS-CoV-2 among previously infected Thai adults in order to inform efforts to control COVID-19 in Thailand. The study subjects were Thais aged &gt;18 years, currently living in Thailand who had two previous COVID-19 infections at least 90 days apart confirmed by either an antigen test or COVID-19 real-time polymerase chain reaction testing, where the reinfection was presumed to be an omicron variant based on the most prominent strain of COVID-19 occurring at the time of reinfection. Study subjects were recruited via advertisements on the social media applications Line and Facebook. Each subject was asked to complete an online questionnaire asking about demographic data, dates of COVID-19 infections, time from the initial infection to reinfection, severity of infection, hospitalizations and symptoms during both infections. The minimum number of subjects determined to be needed for the study was 220. The study was conducted during 12-31 January 2023. A total of 201 subjects were included in the study, 59.7% female. The mean(standard deviation (SD)) age of study subjects was 44.3 (11.4) (range: 20-81) years. The symptoms significantly more common in the first infection than the second infection were: anosmia (36.8%vs 13.9%) (p&lt;0.001), dyspnea (36.3% vs 18.9%) (p&lt;0.001) and myalgia (60.2%vs 43.8%) (=&lt;0.001), respectively. The hospitalization rate was significantly higher during the first infection than the second infection (14.9% vs 3.5%; crude odds ratio (cOR) = 6.25; 95% confidence interval (CI): 2.16-24.71; p&lt;0.001). The average time from first infection to reinfection was 263 (range: 96-725) days. In summary, anosmia, dyspnea, myalgia, and hospitalizations were more common during first than the second COVID-19 infection among study subjects and the time between infections averaged 9 months. We conclude, as COVID-19 immunity decreases over time, there is a need for a booster, possibly updated, vaccine to reduce the risk for reinfection.</description><subject>Adults</subject><subject>Anosmia</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>Dyspnea</subject><subject>Immunity</subject><subject>Infections</subject><subject>Myalgia</subject><subject>Olfaction disorders</subject><subject>Polymerase chain reaction</subject><subject>Real time</subject><subject>Respiration</subject><subject>Respiratory diseases</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Signs and symptoms</subject><subject>Social networks</subject><subject>Vaccines</subject><subject>Viral diseases</subject><issn>0125-1562</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNpNjbtqwzAARTW0kDTNPwg6C_SwZHUUshILHKtIckqmYFv2EEqTxsnSr6-hHTrd4VzOeQBLTChHhAu6AE_TdMI4w-RVLsG3dt7Vam99E2Bhg1HBIDozqEvllY7G2xCtDlDtXL2FsVQWqqKpYoDe2Hpj5ksB320sYTB74w1UuolmhuHNehWdP8BwqAvvdgb-iyH6DB7H9mMa1n-7As3GRF2iym2tVhW6EMluqKO5lBnjgmSdyPuuSyOjnJKetcPQEy6lEDnHDCdMWT_mJJGUshaPnKVsxIKtwMuv93I9f92H6XY8ne_Xzzl5ZARLSYRklP0AgOZNiA</recordid><startdate>20240501</startdate><enddate>20240501</enddate><creator>Assawakosri, Suvichada</creator><creator>Sudhinaraset, Natthinee</creator><creator>Chansaenroj, Jira</creator><creator>Suntronwong, Nungruthai</creator><creator>Kanokudom, Sitthichai</creator><creator>Nalinpakorn, Natach</creator><creator>Tantipraphat, Napat</creator><creator>Sethabutra, Amica</creator><creator>Honsawek, Sittisak</creator><creator>Poovorawan, Yong</creator><general>Central Coordinating Board, SEAMEO-TROPMED Project</general><scope>3V.</scope><scope>7QL</scope><scope>7SS</scope><scope>7T7</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BVBZV</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>P64</scope><scope>PATMY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PYCSY</scope></search><sort><creationdate>20240501</creationdate><title>CORONAVIRUS DISEASE-2019 CHARACTERISTICS AMONG THAI ADULTS REINFECTED WITH SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS-2</title><author>Assawakosri, Suvichada ; Sudhinaraset, Natthinee ; Chansaenroj, Jira ; Suntronwong, Nungruthai ; Kanokudom, Sitthichai ; Nalinpakorn, Natach ; Tantipraphat, Napat ; Sethabutra, Amica ; Honsawek, Sittisak ; Poovorawan, Yong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p183t-b2788435614b67cbbdf32521c3aeec15886675030d023cf71d1dd4a0f53d4f063</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Adults</topic><topic>Anosmia</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>Dyspnea</topic><topic>Immunity</topic><topic>Infections</topic><topic>Myalgia</topic><topic>Olfaction disorders</topic><topic>Polymerase chain reaction</topic><topic>Real time</topic><topic>Respiration</topic><topic>Respiratory diseases</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Signs and symptoms</topic><topic>Social networks</topic><topic>Vaccines</topic><topic>Viral diseases</topic><toplevel>online_resources</toplevel><creatorcontrib>Assawakosri, Suvichada</creatorcontrib><creatorcontrib>Sudhinaraset, Natthinee</creatorcontrib><creatorcontrib>Chansaenroj, Jira</creatorcontrib><creatorcontrib>Suntronwong, Nungruthai</creatorcontrib><creatorcontrib>Kanokudom, Sitthichai</creatorcontrib><creatorcontrib>Nalinpakorn, Natach</creatorcontrib><creatorcontrib>Tantipraphat, Napat</creatorcontrib><creatorcontrib>Sethabutra, Amica</creatorcontrib><creatorcontrib>Honsawek, Sittisak</creatorcontrib><creatorcontrib>Poovorawan, Yong</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>East &amp; South Asia Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Environmental Science Collection</collection><jtitle>Southeast Asian journal of tropical medicine and public health</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Assawakosri, Suvichada</au><au>Sudhinaraset, Natthinee</au><au>Chansaenroj, Jira</au><au>Suntronwong, Nungruthai</au><au>Kanokudom, Sitthichai</au><au>Nalinpakorn, Natach</au><au>Tantipraphat, Napat</au><au>Sethabutra, Amica</au><au>Honsawek, Sittisak</au><au>Poovorawan, Yong</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>CORONAVIRUS DISEASE-2019 CHARACTERISTICS AMONG THAI ADULTS REINFECTED WITH SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS-2</atitle><jtitle>Southeast Asian journal of tropical medicine and public health</jtitle><date>2024-05-01</date><risdate>2024</risdate><volume>55</volume><issue>3</issue><spage>71</spage><epage>86</epage><pages>71-86</pages><issn>0125-1562</issn><abstract>Some severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) omicron subvariants may be resistant to vaccines and/or infection-induced immunity increasing the risk for reinfection. In this study, we aimed to determine coronavirus disease-2019 (COVID-19) severity, need for hospitalization, symptoms and time to reinfection with SARS-CoV-2 among previously infected Thai adults in order to inform efforts to control COVID-19 in Thailand. The study subjects were Thais aged &gt;18 years, currently living in Thailand who had two previous COVID-19 infections at least 90 days apart confirmed by either an antigen test or COVID-19 real-time polymerase chain reaction testing, where the reinfection was presumed to be an omicron variant based on the most prominent strain of COVID-19 occurring at the time of reinfection. Study subjects were recruited via advertisements on the social media applications Line and Facebook. Each subject was asked to complete an online questionnaire asking about demographic data, dates of COVID-19 infections, time from the initial infection to reinfection, severity of infection, hospitalizations and symptoms during both infections. The minimum number of subjects determined to be needed for the study was 220. The study was conducted during 12-31 January 2023. A total of 201 subjects were included in the study, 59.7% female. The mean(standard deviation (SD)) age of study subjects was 44.3 (11.4) (range: 20-81) years. The symptoms significantly more common in the first infection than the second infection were: anosmia (36.8%vs 13.9%) (p&lt;0.001), dyspnea (36.3% vs 18.9%) (p&lt;0.001) and myalgia (60.2%vs 43.8%) (=&lt;0.001), respectively. The hospitalization rate was significantly higher during the first infection than the second infection (14.9% vs 3.5%; crude odds ratio (cOR) = 6.25; 95% confidence interval (CI): 2.16-24.71; p&lt;0.001). The average time from first infection to reinfection was 263 (range: 96-725) days. In summary, anosmia, dyspnea, myalgia, and hospitalizations were more common during first than the second COVID-19 infection among study subjects and the time between infections averaged 9 months. We conclude, as COVID-19 immunity decreases over time, there is a need for a booster, possibly updated, vaccine to reduce the risk for reinfection.</abstract><cop>Bangkok</cop><pub>Central Coordinating Board, SEAMEO-TROPMED Project</pub><tpages>16</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0125-1562
ispartof Southeast Asian journal of tropical medicine and public health, 2024-05, Vol.55 (3), p.71-86
issn 0125-1562
language eng
recordid cdi_proquest_journals_3108816832
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Adults
Anosmia
Coronaviruses
COVID-19
Dyspnea
Immunity
Infections
Myalgia
Olfaction disorders
Polymerase chain reaction
Real time
Respiration
Respiratory diseases
Severe acute respiratory syndrome coronavirus 2
Signs and symptoms
Social networks
Vaccines
Viral diseases
title CORONAVIRUS DISEASE-2019 CHARACTERISTICS AMONG THAI ADULTS REINFECTED WITH SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS-2
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T09%3A08%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=CORONAVIRUS%20DISEASE-2019%20CHARACTERISTICS%20AMONG%20THAI%20ADULTS%20REINFECTED%20WITH%20SEVERE%20ACUTE%20RESPIRATORY%20SYNDROME%20CORONAVIRUS-2&rft.jtitle=Southeast%20Asian%20journal%20of%20tropical%20medicine%20and%20public%20health&rft.au=Assawakosri,%20Suvichada&rft.date=2024-05-01&rft.volume=55&rft.issue=3&rft.spage=71&rft.epage=86&rft.pages=71-86&rft.issn=0125-1562&rft_id=info:doi/&rft_dat=%3Cproquest%3E3108816832%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3108816832&rft_id=info:pmid/&rfr_iscdi=true